4//SEC Filing
Bjarke Henric Bjorn 4
Accession 0001209191-22-013436
CIK 0001693011other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 7:45 AM ET
Size
5.5 KB
Accession
0001209191-22-013436
Insider Transaction Report
Form 4
Bjarke Henric Bjorn
See Remarks
Transactions
- Award
Stock option (right to buy)
2022-02-24+115,000→ 115,000 totalExercise: $5.78Exp: 2032-02-23→ Common Stock (115,000 underlying)
Footnotes (1)
- [F1]The option was granted on February 24, 2022. The shares underlying the option are scheduled to vest in equal monthly installments from February 24, 2022 through February 24, 2026.
Documents
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001652179
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 7:45 AM ET
- Size
- 5.5 KB